Fort Washington Investment Advisors Inc. OH Sells 43,880 Shares of The Ensign Group, Inc. $ENSG

Fort Washington Investment Advisors Inc. OH lessened its holdings in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 26.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 119,251 shares of the company’s stock after selling 43,880 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in The Ensign Group were worth $24,029,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Baillie Gifford & Co. lifted its holdings in shares of The Ensign Group by 62.1% during the 4th quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock valued at $795,964,000 after purchasing an additional 1,750,645 shares in the last quarter. Wasatch Advisors LP raised its holdings in The Ensign Group by 6.0% during the 2nd quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock worth $548,961,000 after buying an additional 199,983 shares during the period. Capital Research Global Investors lifted its stake in The Ensign Group by 7.2% in the third quarter. Capital Research Global Investors now owns 2,016,101 shares of the company’s stock valued at $348,322,000 after buying an additional 136,260 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of The Ensign Group by 3.4% in the fourth quarter. Geode Capital Management LLC now owns 1,498,673 shares of the company’s stock valued at $261,107,000 after buying an additional 49,117 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of The Ensign Group by 9.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company’s stock valued at $232,124,000 after buying an additional 118,110 shares during the period. 96.12% of the stock is currently owned by institutional investors.

The Ensign Group Stock Performance

NASDAQ ENSG opened at $163.05 on Monday. The Ensign Group, Inc. has a 52 week low of $134.79 and a 52 week high of $218.00. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56. The stock’s 50 day moving average price is $171.64 and its two-hundred day moving average price is $185.03. The stock has a market capitalization of $9.53 billion, a price-to-earnings ratio of 26.56, a PEG ratio of 1.59 and a beta of 0.68.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The company had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.40 billion. During the same period last year, the business earned $1.52 EPS. The business’s quarterly revenue was up 18.4% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. As a group, analysts anticipate that The Ensign Group, Inc. will post 6.82 earnings per share for the current fiscal year.

The Ensign Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a dividend of $0.065 per share. The ex-dividend date is Tuesday, June 30th. This represents a $0.26 annualized dividend and a yield of 0.2%. The Ensign Group’s dividend payout ratio is presently 4.23%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ENSG shares. Weiss Ratings lowered shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of The Ensign Group in a research note on Tuesday, June 9th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, The Ensign Group presently has an average rating of “Moderate Buy” and an average price target of $216.75.

Insiders Place Their Bets

In related news, Director Barry M. Smith sold 700 shares of the firm’s stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $196.65, for a total value of $137,655.00. Following the completion of the transaction, the director owned 22,152 shares of the company’s stock, valued at approximately $4,356,190.80. This trade represents a 3.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction on Monday, April 20th. The shares were sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the sale, the director owned 9,295 shares in the company, valued at $1,858,721.15. The trade was a 4.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 2,592 shares of company stock valued at $478,246. 4.00% of the stock is owned by insiders.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.